Comment on “Genomics in medicine”
Main Article Content
Keywords
Genomics, Microarrays, Human genome
Abstract
I would like to make some comments regarding the article “La genómica en la medicina” ("The genome in medicine") published in the Rev Med Inst Mex Seguro Soc 2014;52(5):566-73.
Dr. Ruiz Esparza-Garrido et al. analyze in a simple and didactic way the major changes that have occurred in recent decades in the study of the genome oriented to applied medicine; for this, omic technologies are used to structurally and functionally examine the human genome. In particular, a brief description was made of the massive sequencing, microarrays, some aspects of proteomics, such as networks or pathways for intracellular signaling, metabolomics, and the utility of bioinformatic support to analyze and interpret the large amount of data produced in these studies. This commentary is intended to highlight some of the latest and most outstanding developments published in this area, which will lead us to a modernized medical practice.
References
Kitchen RR, Rozowsky JS, Gerstein MB, Nairn AC. Decoding neuroproteomics: integrating the genome, translatome and functional anatomy. Nature Neurosci. 2014;17:1491-9.
Wang E, Zaman N, McGee S, Milanese JS, Masoudi-Nejad A, O’Connor-McCourt M. Predictive genomics: A cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data. Sem Cancer Biol. 2014;Apr 18 (Epub ahead of print).
Garray LA, Verweij J. Precision oncology: an overview. J Clin Oncol. 2014;31:1803-5.
[No authors listed.] FDA-approved next-generation sequencing system could expand clinical genomic testing: experts predict MiSeqDX system will make genetic testing more affordable for smaller labs. Am J Med Genet A. 2014;164A:x-xi.
Collins FS, Hamburg MA. First FDA authorization for next-generation sequencer. N Engl J Med. 2013;369:2369-71.
Huser V, Sincan M, Cimino JJ. Developing genomic knowledge bases and databases to support clinical management: current perspectives. Pharmacogenomics Pers Med. 2014;7:275-83.
Van Allen EM, Wagle N, Levy MA. Clinical analysis and interpretation of cancer genome data. J Clin Oncol. 2013;31:1825-33.
Doudna J, Charpentier E. The new frontier of genome engineering with CRISPR-Cas9. Science. 2014;346:1258096.